Login / Signup

Enhancing early detection of neurological and developmental disorders and provision of intervention in low-resource settings in Uttar Pradesh, India: study protocol of the G.A.N.E.S.H. programme.

Moreno ToldoSwami VarishthanandaChrista EinspielerNeeraj TripathiAnshu SinghSurendra K VermaKanchan VishwakarmaDajie ZhangAgyeya DwivediRitika GuptaSanjay KarnNirmal KerkettaRam NarayanKaruna Nikam SinghSumitra RaniAkanksha SinghDivyanshu SinghKrishna Pratap SinghNavin SinghNeeraj SinghRishi SinghShyam P SinghRakesh SrivastavaSandeep SrivastavaSanjeev SrivastavaGopal YadavPreeti YadavSheshnath YadavSujata YadavPeter B Marschik
Published in: BMJ open (2020)
G.A.N.E.S.H. received ethics approval from the Indian Government Chief Medical Officers of Varanasi and Mirzapur and from the Ramakrishna Mission Home of Service in Varanasi. GMA is a worldwide used diagnostic tool, approved by the Ethics Committee of the Medical University of Graz, Austria (27-388 ex 14/15). Apart from peer-reviewed publications, we are planning to deploy G.A.N.E.S.H. in other vulnerable settings.
Keyphrases
  • healthcare
  • study protocol
  • randomized controlled trial
  • public health
  • big data
  • mental health
  • drug administration
  • clinical trial
  • open label
  • artificial intelligence
  • subarachnoid hemorrhage
  • brain injury